Literature DB >> 18484878

Characteristics and treatment outcome of cerebrospinal fluid shunt-associated infections in adults: a retrospective analysis over an 11-year period.

Anna Conen1, Laura Naemi Walti, Adrian Merlo, Ursula Fluckiger, Manuel Battegay, Andrej Trampuz.   

Abstract

BACKGROUND: Data on infections associated with cerebrospinal fluid (CSF) shunts among adults are limited. Therefore, we performed a retrospective study of shunt-associated infections in adults.
METHODS: Patients aged > or = 12 years with infections associated with CSF shunts and admitted to our institution(University Hospital Basel, Basel, Switzerland) from January 1996 through December 2006 were included retrospectively. Hospital charts were reviewed, and follow-up was performed by assessment of later hospitalizations and telephone contact with patients, their families, and general practitioners.
RESULTS: Seventy-eight episodes of infection associated with ventriculoperitoneal shunt (65 episodes), ventriculoatrial shunt (7), lumboperitoneal shunt (5), and central nervous system reservoir (1) were included. Median patient age was 50 years (range, 12-80 years); 49 (63%) of the patients were men. Most infections (48 [62%])manifested within 1 month after shunt surgery. Fever was present in 61 episodes (78%), neck stiffness was present in 35 (45%), and local signs of infection were present in 38 (49%). In CSF, leukocyte count was >5 x 10(6) cells/L in 80% of episodes, and lactate level was 11.9 mmol/L in 81% of episodes. Leukocyte counts were significantly higher in CSF obtained by use of lumbar puncture (median leukocyte count, 573 x 10(6) cells/L; P = .001) and valve puncture (median leukocyte count, 484 x 10(6) cells/L; P = .016) than in ventricular CSF (median leukocyte count, 8.5 x 10(6) cells/L). Overall, results of CSF cultures were positive in 66% of episodes (48 of 73 episodes for which CSF was collected), and microorganisms were isolated more often from valve puncture CSF specimens(91% of specimens) and ventricular CSF specimens (70%) than from lumbar CSF specimens (45%). The most prevalent organisms were coagulase-negative staphylococci (found in 37% of specimens), Staphylococcus aureus(18%), and Propionibacterium acnes (9%). A surgical procedure was performed to treat infection in 63 (81% of the episodes) (shunt removal in 37 episodes and shunt replacement in 26). The shunt was retained without surgery for 15 episodes (19% of episodes). Median duration of patient follow-up was 4.6 years (range, 0.1-11.1 years),with favorable treatment outcome in 75 (96%) of 78 cases. One of the 63 patients who underwent surgical treatment of shunt-associated infection experienced infection relapse; of the 15 patients who received treatment with antibiotics alone, 1 experienced infection relapse and 1 died. The 2 relapses involved rifampin-resistant coagulase-negative staphylococci.
CONCLUSIONS: Shunt-associated infections among adults often present with nonspecific clinical signs, and affected patients can have normal CSF leukocyte counts and lactate levels; therefore, a high index of suspicion and improved methods are required for diagnosing shunt-associated infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18484878     DOI: 10.1086/588298

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  57 in total

Review 1.  Neuro-intensive care of patients with acute CNS infections.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 2.  Cerebrospinal fluid diversion devices and infection. A comprehensive review.

Authors:  R Gutiérrez-González; G R Boto; A Pérez-Zamarrón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-30       Impact factor: 3.267

3.  Characterization of bacterial isolates collected from a sheep model of osseointegration.

Authors:  Dustin L Williams; Roy D Bloebaum; James P Beck; Cathy A Petti
Journal:  Curr Microbiol       Date:  2010-05-11       Impact factor: 2.188

Review 4.  Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.

Authors:  Matthijs C Brouwer; Allan R Tunkel; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

5.  Prevention options for ventriculoperitoneal shunt infections: a retrospective analysis during a five-year period.

Authors:  Xing Wu; Qin Liu; Xiaofei Jiang; Tao Zhang
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  Intervertebral disc penetration by antibiotics used prophylactically in spinal surgery: implications for the current standards and treatment of disc infections.

Authors:  Manu N Capoor; Jan Lochman; Andrew McDowell; Jonathan E Schmitz; Martin Solansky; Martina Zapletalova; Todd F Alamin; Michael F Coscia; Steven R Garfin; Radim Jancalek; Filip Ruzicka; A Nick Shamie; Martin Smrcka; Jeffrey C Wang; Christof Birkenmaier; Ondrej Slaby
Journal:  Eur Spine J       Date:  2018-12-01       Impact factor: 3.134

7.  The distribution of infection with Propionibacterium acnes is equal in patients with cervical and lumbar disc herniation.

Authors:  Naghmeh Javanshir; Firooz Salehpour; Javad Aghazadeh; Farhad Mirzaei; Seyed Ahmad Naseri Alavi
Journal:  Eur Spine J       Date:  2017-07-15       Impact factor: 3.134

Review 8.  Antimicrobial treatment options for neurosurgical ventricular shunt infections in children from 1993 to 2012: a systematic review.

Authors:  Richard J Drew; Theresa S Cole; Maggie K Lee; Stéphane Paulus; Conor L Mallucci; Andrew Riordan
Journal:  Childs Nerv Syst       Date:  2013-12-10       Impact factor: 1.475

9.  Relationship of causative organism and time to infection among children with cerebrospinal fluid shunt infection.

Authors:  Matthew R Test; Kathryn B Whitlock; Marcie Langley; Jay Riva-Cambrin; John R W Kestle; Tamara D Simon
Journal:  J Neurosurg Pediatr       Date:  2019-05-03       Impact factor: 2.375

10.  Soluble membrane attack complex is diagnostic for intraventricular shunt infection in children.

Authors:  Theresa N Ramos; Anastasia A Arynchyna; Tessa E Blackburn; Scott R Barnum; James M Johnston
Journal:  JCI Insight       Date:  2016-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.